Блокаторы ангиотензиновых рецепторов в современных рекомендациях по лечению и профилактике сердечно-сосудистых заболеваний
СВ Моисеев, ВВ Фомин - Клиническая фармакология и терапия, 2008 - elibrary.ru
ЕЛЬЮ РАЗРАБОТКИ блокаторов ангиотензино-вых рецепторов было получить
препараты, оказывающие более селективное действие на ре-нин-ангиотензиновую …
препараты, оказывающие более селективное действие на ре-нин-ангиотензиновую …
Therapeutic targets for heart failure: beyond beta-adrenergic and renin-angiotensin system blockade
K Iwatsubo, Y Ishikawa - Recent Patents on Cardiovascular …, 2008 - ingentaconnect.com
Heart failure is a major healthcare problem and leading cause of death in Western countries.
Growing evidence has shown recent improvements in pharmacological therapy, such as …
Growing evidence has shown recent improvements in pharmacological therapy, such as …
New guidelines of the European Society of Hypertension
J Segura, LM Ruilope - Current hypertension reports, 2008 - search.proquest.com
In June 2007, the European Society of Hypertension and the European Society of
Cardiology published the new joint edition of the European Guidelines for the Management …
Cardiology published the new joint edition of the European Guidelines for the Management …
[PDF][PDF] La terapia alla dimissione tra standardizzazione e personalizzazione
GF Mureddu, V Rizzello, A Boccanelli - G Ital Cardiol, 2008 - researchgate.net
La strategia terapeutica dovrebbe essere caratterizzata sia da un elevato grado di
standardizzazione, ovverosia dalla massima aderenza alle raccomandazioni delle linee …
standardizzazione, ovverosia dalla massima aderenza alle raccomandazioni delle linee …
Implicaciones clínicas del programa ONTARGET en pacientes con cardiopatía isquémica crónica
R Vidal-Pérez, JR González-Juanatey - Revista española de cardiología …, 2008 - Elsevier
Las guías de práctica clínica indican que en la estrategia terapéutica de la gran mayoría de
los pacientes con cardiopatía isquémica crónica (CIC) debe incluirse un fármaco que …
los pacientes con cardiopatía isquémica crónica (CIC) debe incluirse un fármaco que …
Management of coronary artery disease in Type 2 diabetes mellitus
JL Petersen, DK McGuire - Type 2 Diabetes Mellitus: An Evidence-Based …, 2008 - Springer
Coronary artery disease (CAD) is the most common cause of death for patients with diabetes
mellitus (DM). Patients with CAD and DM constitute roughly one quarter of the total CAD …
mellitus (DM). Patients with CAD and DM constitute roughly one quarter of the total CAD …
Neurohormonal Blockade in Heart Failure
RR Baliga - Management of Heart Failure: Volume 1: Medical, 2008 - Springer
Neurohormonal blockade reduces symptoms of heart failure (HF), reverses cardiac
remodeling, and improves survival, and therefore it is the mainstay in the management of …
remodeling, and improves survival, and therefore it is the mainstay in the management of …
[PDF][PDF] Review article Do angiotensin receptor blockers increased the risk of myocardial infarction? The landscape after ONTARGET study
S Grajek - Kardiologia Polska (Polish Heart Journal), 2008 - journals.viamedica.pl
Adres do korespondencji: prof. dr hab. n. med. Stefan Grajek, I Klinika Kardiologii,
Uniwersytet Medyczny, ul. Długa 1/2, 61-848 Poznań, tel.:+ 48 61 854 91 46,+ 48 601 740 …
Uniwersytet Medyczny, ul. Długa 1/2, 61-848 Poznań, tel.:+ 48 61 854 91 46,+ 48 601 740 …
Medical management of advanced heart failure
JP Rocchiccioli, JJV McMurray - Progress in Palliative Care, 2008 - Taylor & Francis
Medical management of advanced heart failure Page 1 Medical management of advanced heart
failure J. Paul Rocchiccioli, John JV McMurray British Heart Foundation, Glasgow …
failure J. Paul Rocchiccioli, John JV McMurray British Heart Foundation, Glasgow …